يعرض 61 - 80 نتائج من 67,663 نتيجة بحث عن '(((( 5 a decrease ) OR ( 50 ((we decrease) OR (nn decrease)) ))) OR ( 50 mm decrease ))', وقت الاستعلام: 0.93s تنقيح النتائج
  1. 61

    Moving distances in the open-field. حسب Wataru Matsunaga (3452621)

    منشور في 2023
    الموضوعات:
  2. 62
  3. 63
  4. 64
  5. 65
  6. 66
  7. 67
  8. 68

    Advancing the science of NOWS research. حسب Sarah E. Maylott (14560785)

    منشور في 2024
    "…<div><p>Every 15 minutes in the US, an infant exposed to opioids is born. Approximately 50% of these newborns will develop Neonatal Opioid Withdrawal Syndrome (NOWS) within 5 days of birth. …"
  9. 69

    Protocol measures. حسب Sarah E. Maylott (14560785)

    منشور في 2024
    "…<div><p>Every 15 minutes in the US, an infant exposed to opioids is born. Approximately 50% of these newborns will develop Neonatal Opioid Withdrawal Syndrome (NOWS) within 5 days of birth. …"
  10. 70

    Cry variables. حسب Sarah E. Maylott (14560785)

    منشور في 2024
    "…<div><p>Every 15 minutes in the US, an infant exposed to opioids is born. Approximately 50% of these newborns will develop Neonatal Opioid Withdrawal Syndrome (NOWS) within 5 days of birth. …"
  11. 71
  12. 72

    Table1_Discontinuation of afterload-reducing drugs decreases left ventricular outflow tract obstruction in hypertrophic obstructive cardiomyopathy.docx حسب Anselm A. Derda (5866220)

    منشور في 2024
    "…</p>Results<p>16 patients discontinued their afterload-reducing drugs, resulting in a significant decrease in median LVOT gradient from 86.5 [60.5–109.3] mmHg to 61.5 [28.3–97.50] mmHg (p = 0.0004). …"
  13. 73

    Table1_Discontinuation of afterload-reducing drugs decreases left ventricular outflow tract obstruction in hypertrophic obstructive cardiomyopathy.docx حسب Anselm A. Derda (5866220)

    منشور في 2024
    "…</p>Results<p>16 patients discontinued their afterload-reducing drugs, resulting in a significant decrease in median LVOT gradient from 86.5 [60.5–109.3] mmHg to 61.5 [28.3–97.50] mmHg (p = 0.0004). …"
  14. 74
  15. 75

    Flow chart of the study procedures. حسب Kazuhiko Ikeuchi (9234268)

    منشور في 2023
    "…Pre-treatment spontaneous decrease of RPR titer was associated with a slower decrease in post-treatment RPR titer.…"
  16. 76
  17. 77
  18. 78
  19. 79
  20. 80

    Discovery of the Triazolo[1,5‑<i>a</i>]Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming Multidrug Resistance... حسب Shuai Wang (109515)

    منشور في 2021
    "…Here, we reported our medicinal chemistry efforts that led to the discovery of the triazolo­[1,5-<i>a</i>]­pyrimidine derivative <b>WS-898</b> as a highly effective ABCB1 inhibitor capable of reversing paclitaxel (PTX) resistance in drug-resistant SW620/Ad300, KB-C2, and HEK293/ABCB1 cells (IC<sub>50</sub> = 5.0, 3.67, and 3.68 nM, respectively), more potent than verapamil and zosuquidar. …"